Edgewise Therapeutics, Inc. (EWTX) has a consensus analyst rating of Buy, based on 9 analysts covering the stock. Of those, 7 recommend buying, 1 recommend holding, and 1 recommend selling.
The analyst consensus price target for EWTX is $38.67, representing a +16.6% upside from the current price of $33.16. Price targets range from a low of $25.00 to a high of $46.00.
